

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | NMDA receptor ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kynurenic acid | ✔ | 97% | |||||||||||||||||
| Dizocilpine maleate |
+++
NMDA receptor, Kd: 37.2 nM |
99%+ | |||||||||||||||||
| Felbamate |
+
NMDAR, IC50: 1.8 mM |
98% | |||||||||||||||||
| (-)-Dizocilpine maleate |
++++
NMDA receptor, Ki: 30.5 nM |
98% | |||||||||||||||||
| Ifenprodil tartrate |
+++
NMDA Receptor, IC50: 0.3 μM |
98% | |||||||||||||||||
| Spermidine | ✔ | Autophagy | 98% GC | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 产品名称 | AMPA receptor ↓ ↑ | GluR ↓ ↑ | mGluR5 ↓ ↑ | NMDA receptor ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evans Blue | ✔ | 85% (Dye content) | |||||||||||||||||
| IEM-1754 |
+
GluR1, IC50: 6 μM GluR3, IC50: 6 μM |
99% | |||||||||||||||||
| Latrepirdine 2HCl | ✔ | 99% | |||||||||||||||||
| (-)-Huperzine A |
+++
AChE (G4 form), Ki: 7 nM |
98% | |||||||||||||||||
| CTEP |
++++
mGlu5, IC50: 2.2 nM |
98%+ | |||||||||||||||||
| MPEP |
++
mGluR5, IC50: 36 nM |
99%+ | |||||||||||||||||
| Riluzole | ✔ | 97% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Traxoprodil (CP101,606) is a potent and selective NMDA antagonist and protect hippocampal neurons with an IC50 of 10 nM. Traxoprodil is potent at blocking haloperidol-induced catalepsy and with an ED50 less than 1 mg/kg. Traxoprodil is effective at 1 mg/kg to block NMDA (ip) stimulated cfos induction in mice[3]. Traxoprodil at a dose of 20 and 40 mg/kg exhibited antidepressant activity in the FST (forced swim test) and it was not related to changes in animals' locomotor activity[4]. Traxoprodil (20nmol i.c.v.) increased the latency to generalized tonic-clonic seizures induced by PTZ (70mg/kg; i.p.). Traxoprodil (60mg/kg, p.o.) increased the latency to clonic and generalized seizures, and decreased the total time spent in seizures[5]. |
| Administration | Dosage | Frequency | Description | References | ||
| Wistar rats | Wistar rats | 0.05, 3, 7, and 15 mg/kg | Evaluate the blocking effect of CP-101,606 on σ1R | Pharmaceuticals (Basel). 2022 Aug 2;15(8):960 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT00163085 | Parkinson's Disease | Phase 2 | Completed | - | United States, Oregon ... 展开 >> Pfizer Investigational Site Portland, Oregon, United States, 97239 收起 << |
| NCT00163059 | Depressive Disorder, Major | Phase 2 | Completed | - | United States, Kansas ... 展开 >> Pfizer Investigational Site Wichita, Kansas, United States, 67214-2878 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.05mL 0.61mL 0.31mL |
15.27mL 3.05mL 1.53mL |
30.54mL 6.11mL 3.05mL |
|
| CAS号 | 134234-12-1 |
| 分子式 | C20H25NO3 |
| 分子量 | 327.42 |
| SMILES Code | OC1(C2=CC=CC=C2)CCN([C@@H](C)[C@@H](O)C3=CC=C(O)C=C3)CC1 |
| MDL No. | MFCD00926469 |
| 别名 | CP101,606; CP 98,113; (+)-CP 101,606 |
| 运输 | 蓝冰 |
| InChI Key | QEMSVZNTSXPFJA-HNAYVOBHSA-N |
| Pubchem ID | 219101 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 60 mg/mL(183.25 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1